Correction: BiDil for Heart Failure in Black Patients. Ann Intern Med. 2007;146:616. doi: 10.7326/0003-4819-146-8-200704170-00023
Download citation file:
Published: Ann Intern Med. 2007;146(8):616.
The recent article by Bibbins-Domingo and Fernandez (1) incorrectly stated that “increased levels of nitric oxide in black people that are associated with adverse heart failure outcomes and may be reduced by hydralazine hydrochloride–isosorbide nitrate therapy.” This statement should read that “lower levels of available nitric oxide in black people are associated with adverse heart failure outcomes and may be enhanced by hydralazine hydrochloride–isosorbide nitrate therapy.”
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only